Market Cap

China Resources Double-Crane Pharmaceutical Co.,Ltd. Market Capitalization:

CN¥19.73 Billion

CNY as of July 1, 2024

US$2.71 Billion

business China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Profile

China Resources Double-Crane Pharmaceutical Co.,Ltd. Main Stock Listing

SSE: 600062

Market Capitalization History of China Resources Double-Crane Pharmaceutical Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of China Resources Double-Crane Pharmaceutical Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥19.00 B -4.51%
Jan. 1, 2023 CN¥19.89 B 61.33%
Jan. 1, 2022 CN¥12.33 B 5.60%
Jan. 1, 2021 CN¥11.68 B -18.37%
Jan. 1, 2020 CN¥14.30 B 26.68%
Jan. 1, 2019 CN¥11.29 B -43.43%
Jan. 1, 2018 CN¥19.96 B 15.88%
Jan. 1, 2017 CN¥17.23 B 43.42%
Jan. 1, 2016 CN¥12.01 B -24.86%
Jan. 1, 2015 CN¥15.99 B 11.92%
Jan. 1, 2014 CN¥14.28 B -19.90%
Jan. 1, 2013 CN¥17.83 B 83.25%
Jan. 1, 2012 CN¥9.73 B -47.45%
Jan. 1, 2011 CN¥18.52 B 6.38%
Jan. 1, 2010 CN¥17.41 B -1.59%
Jan. 1, 2009 CN¥17.69 B -1.29%
Jan. 1, 2008 CN¥17.92 B 176.02%
Jan. 1, 2007 CN¥6.49 B 85.89%
Jan. 1, 2006 CN¥3.49 B 39.33%
Jan. 1, 2005 CN¥2.51 B -79.92%
Jan. 1, 2004 CN¥12.49 B 57.35%
Jan. 1, 2003 CN¥7.94 B 18.51%
Jan. 1, 2002 CN¥6.70 B -20.35%
Jan. 1, 2001 CN¥8.41 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

China Resources Double-Crane Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: SSE: 600062

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.